(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEXUS PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NEXUS PHARMACEUTICALS

ST13

US500000088241191

Class

5

Filing

88241191

Registration

5970504

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

04/22/2026

Trademark type

Combined

Nice classes

5

Filing date

12/25/2018

Registration date

01/28/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/21/2026

Last transaction

04/22/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

08/14/2017

First use in commerce

08/14/2017

Drawing code

3

Owner type

03

Owner location

Lincolnshire, IL, US

Examiner

KETCHUM, BRENDAN J

Current location

Historical data usage

Mark description

The mark consists of two sets of two parallelograms where each parallelogram in each set shares a common side with the other parallelogram in the set, the longer sides of one parallelogram in each set of parallelograms are substantially vertical and the longer sides of the other parallelogram in each set of parallelograms are substantially horizontal, the parallelograms in each set of parallelograms interface to form a triangle in the interface zone, the parallelograms with longer sides substantially vertical are blue in the non-interface zones and the parallelograms with longer sides substantially horizontal are yellow at the end furthest from the interface zones fading into green closer to and adjacent to the interface zones, the triangles of the interface zones are blue and green faded together, the shared sides of the sets of parallelograms are parallel and offset from each other with a space in between the sets of parallelograms, the space formed by the parallel shared sides angles from left to right from the bottom of the parallel shared sides to the top of the parallel shared sides, and the sets of parallelograms combine to form a butterfly-like structure; the word "NEXUS" in black all-capital letters on a line to the right of the butterfly-like structure and extending from the middle of the lowermost parallelogram to significantly below the butterfly-like structure; and the word "PHARMACEUTICALS" in black all-capital letters below the word "NEXUS" in a smaller font than the word "NEXUS" and full justified with the word "NEXUS".

Holders and representatives

Holders

Nexus Pharmaceuticals, Inc.

Representatives

Umair A. Qadeer QADEER LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of cancer ; Pharmaceutical preparations for the treatment of asthma

Publications

History of USPTO decisions and trademark events.

22 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/21/2026

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/21/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/21/2026

E815

TEAS SECTION 8 & 15 RECEIVED

01/28/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/28/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/29/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/29/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/29/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/28/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/12/2019

PUBO

PUBLISHED FOR OPPOSITION

11/12/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/23/2019

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/09/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/08/2019

ALIE

ASSIGNED TO LIE

10/07/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/18/2019

GNSL

LETTER OF SUSPENSION E-MAILED

03/18/2019

CNSL

SUSPENSION LETTER WRITTEN

03/18/2019

DOCK

ASSIGNED TO EXAMINER

03/18/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/18/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/17/2019

NWAP

NEW APPLICATION ENTERED

12/28/2018

Continuous trademark protection

Get notified about every new filing that threatens NEXUS PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.